GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Malaysian Genomics Resource Centre Bhd (XKLS:0155) » Definitions » Revenue

Malaysian Genomics Resource Centre Bhd (XKLS:0155) Revenue : RM4.59 Mil (TTM As of Sep. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Malaysian Genomics Resource Centre Bhd Revenue?

Malaysian Genomics Resource Centre Bhd's revenue for the three months ended in Sep. 2023 was RM2.27 Mil. Its revenue for the trailing twelve months (TTM) ended in Sep. 2023 was RM4.59 Mil. Malaysian Genomics Resource Centre Bhd's Revenue per Share for the three months ended in Sep. 2023 was RM0.02. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was RM0.04.

Warning Sign:

Malaysian Genomics Resource Centre Bhd revenue per share has been in decline for the last 5 years.

During the past 12 months, the average Revenue per Share Growth Rate of Malaysian Genomics Resource Centre Bhd was -71.60% per year. During the past 3 years, the average Revenue per Share Growth Rate was -59.30% per year. During the past 5 years, the average Revenue per Share Growth Rate was -44.60% per year. During the past 10 years, the average Revenue per Share Growth Rate was -16.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Malaysian Genomics Resource Centre Bhd's highest 3-Year average Revenue per Share Growth Rate was 158.80% per year. The lowest was -69.30% per year. And the median was -22.10% per year.


Malaysian Genomics Resource Centre Bhd Revenue Historical Data

The historical data trend for Malaysian Genomics Resource Centre Bhd's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Malaysian Genomics Resource Centre Bhd Revenue Chart

Malaysian Genomics Resource Centre Bhd Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.87 26.16 0.28 0.95 1.78

Malaysian Genomics Resource Centre Bhd Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.33 3.81 1.64 0.68 2.27

Competitive Comparison of Malaysian Genomics Resource Centre Bhd's Revenue

For the Diagnostics & Research subindustry, Malaysian Genomics Resource Centre Bhd's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Malaysian Genomics Resource Centre Bhd's Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Malaysian Genomics Resource Centre Bhd's Revenue distribution charts can be found below:

* The bar in red indicates where Malaysian Genomics Resource Centre Bhd's Revenue falls into.



Malaysian Genomics Resource Centre Bhd Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was RM4.59 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Malaysian Genomics Resource Centre Bhd  (XKLS:0155) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Malaysian Genomics Resource Centre Bhd Revenue Related Terms

Thank you for viewing the detailed overview of Malaysian Genomics Resource Centre Bhd's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Malaysian Genomics Resource Centre Bhd (XKLS:0155) Business Description

Traded in Other Exchanges
N/A
Address
8F, Jalan Teknologi 3/6, Taman Sains, Petaling Jaya, SGR, MYS, 47810
Malaysian Genomics Resource Centre Bhd is a Malaysia-based company engaged in providing laboratory services. It primarily offers genome sequencing and analysis (GSA) services, genetic screening services (GSS), and pathology services. GSA services involve the sequencing and analysis of the DNA of humans, animals, plants, and microbes, to discover meaningful biological information. The company is engaged in providing GSS by developing its own range of genetic screening tests under the brand Dtect which screen human DNA for genetic markers related to diseases and health conditions. It derives the majority of its revenue from Pathology services.

Malaysian Genomics Resource Centre Bhd (XKLS:0155) Headlines

No Headlines